Coeptis Therapeutics Holdings Inc
Change company Symbol lookup
Select an option...
COEP Coeptis Therapeutics Holdings Inc
IRM Iron Mountain Inc
DXCM Dexcom Inc
APLS Apellis Pharmaceuticals Inc
RA Brookfield Real Assets Income Fund Inc.
KRNLU Kernel Group Holdings Inc
XPEV Xpeng Inc
ETN Eaton Corporation PLC
MO Altria Group Inc
DM Desktop Metal Inc
Go

Company profile

Coeptis Therapeutics Holdings, Inc., together with its subsidiaries, including Coeptis Therapeutics, Inc. and Coeptis Pharmaceuticals, Inc., is a biopharmaceutical company. The Company is focused on developing cell therapy platforms for cancer. The Company's product portfolio and rights are highlighted by a universal, multi-antigen chimeric antigen receptor (CAR)-T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK) and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the Company is developing with VyGen-Bio and medical researchers at the Karolinska Institute. Its CAR therapy is a treatment for cancer in which a patient's T cells (a type of immune cell) are genetically engineered to recognize cancer cells to target and destroy them. Its CAR T therapies are revolutionizing the treatment of many blood cancers, including B cell leukemias and lymphomas by targeting specific proteins found in these cancers.

Closing Price
$2.14
Day's Change
0.0245 (1.16%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.15
Day's Low
2.01
Volume
(Light)
Volume:
49,176

10-day average volume:
118,838
49,176
  • Prev Close
    2.12
  • Today's Open
    2.15
  • Day's Range
    2.01-2.15
  • Avg Vol (10-day)
    118.8K
  • Last (time)
    12:32p ET 11/25/22
  • Last (size)
    102
  • 52-Wk Range
    1.98 - 21.42
    LowHigh
  • (10/28/22 - 11/23/22)
    8.31%
  • 85.8%
  • Market Cap
    42.1M
  • Shares Outstanding
    5.1M
  • 0.62
  • 3.44x
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 54.11
  • (% of float 11/15/22)
    0.14

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.